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ABSTRACT OF THESIS
The Prevalence of Temporomandibular Disorders in Fibromyalgia Patients
Compared to That of Failed Back Syndrome Patients: A Blinded Prospective
Study.
The purpose of this study was to determine the prevalence of
temporomandibular disorders (TMD) in fibromyalgia (FM) patients compared to
failed back syndrome (FBS) patients. In addition, the FM and FBS patients were
assessed and compared with regard to their psychosocial dysfunction. The study
included 51 adult patients (FM = 32, FBS = 19) recruited from a physical
medicine and rehabilitation clinic and a FM workshop. Questionnaires included
an orofacial pain questionnaire and a battery of psychological questionnaires that
included the Symptom Check List-90-Revised, the Pittsburgh Sleep Quality
Index, the Multi-dimensional Pain Inventory, the Post-traumatic Stress Disorder
Checklist-Civilian Version, and Multidimensional Fatigue Symptoms Inventoryshort form. Each patient underwent a clinical examination by a dentist who was
blind to the diagnostic category and if applicable was diagnosed with TMD based
on the Research Diagnostic Criteria for TMD. Fifty three percent of the FM
patients reported having face pain compared to 11% of the FBS patients
(P=0.002). Of those FM patients who reported face pain, 71% fulfilled the criteria
for TMD. The psychometric data revealed that the FM patients had higher scores
for somatization (P=0.02) and obsessive-compulsive (P=0.009) subscales
compared to the FBS patients. The mean score of medication used to sleep was
higher among the FM patients compared to FBS patients (P=0.002). Eighty
seven percent of the FM patients reported a stressful event (P=0.036). Of those
FM patients who reported a stressful event 42.3% were deemed post-traumatic
stress disorder positive. FM patient also had higher scores for general fatigue
(P<0.0001), emotional fatigue (P=0.008), physical fatigue (P<0.0001) and mental
fatigue (P<0.0001) as compared to FBS patients. The high prevalence of TMD
and psychosocial dysfunction among FM patients suggests a dysfunctional
hypothalamic-pituitary-adrenal axis and dysregulated autonomic nervous system.
KEYWORDS: Prevalence, temporomandibular disorders, fibromyalgia, failed
back syndrome and psychosocial dysfunction.
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Chapter 1. Introduction

Fibromyalgia (FM) is defined as a syndrome of widespread pain and
stiffness of the locomotor system. Symptoms last at least 3 months with the
presence of palpable tenderness at 11 or more of 18 established areas involving
all four body quadrants. This definition is based on findings from a study
performed by the Multicenter Criteria Committee to define FM and was later
adopted by the American Academy of Rheumatology (ACR) 1. A more detailed
explanation of the ACR criteria for FM is illustrated in Figure 1 and Table 1. In
addition, the Multicenter Criteria Committee highlighted symptoms commonly
associated with FM such as sleep disturbances, fatigue, paresthesias, anxiety,
headache and irritable bowel syndrome (IBS) 1. FM is estimated to affect 2% of
the general population, with a large female preponderance. The syndrome
increases in prevalence with age 2.
FM may be classified as primary or secondary, depending on the nature of
its onset 3. The primary form occurs in adults without association to a known

1

illness, whereas secondary FM is based on preexisting underlying medical
disorders such as rheumatoid arthritis, infection, stress, or trauma inducing the
condition

4 5

. In spite of the above mentioned classification, the exact etiology of

FM remains elusive and is further complicated by comorbid conditions. These
comorbidities include that of other “functional somatic syndromes” such as
chronic

fatigue

syndrome

(CFS),

irritable

bowel

syndrome

(IBS),

temporomandibular disorders (TMD), multiple chemical sensitivities, and tensiontype headache, all of which, including FM, have a degree of overlap in core
symptoms 6 7.
Temporomandibular disorders (TMD) is a collective term embracing a
number of clinical problems that involve the masticatory musculature, the
temporomandibular joints and associated structures 8. It includes a subset of
musculoskeletal diagnoses which typically involve the temporomandibular joint
(TMJ) and/or the muscles of mastication. Common TMJ diagnoses include
degenerative joint disorders like osteoarthritis, arthralgia or disk displacements
and are associated with preauricular pain, limited functional jaw movements, jaw
clicking and/or locking. Muscle disorders include myofascial pain, typically
presenting as myalgia with local trigger points in muscle bands that can refer
pain to a remote site. Limited range of jaw movement secondary to reports of
muscle fatigue is also commonly observed 9 8 10 11.
In spite of large percentages of the general population exhibiting signs and
symptoms of TMD
7%

12

13 14 15 16 9 17 18

, the need for treatment is estimated to range between 3.6-

. This highlights the fact that TMD cases are cyclic in nature,

2

often self-limiting and mild, and rarely progress to a severe disabling chronic
state 19 20 9 21.

Copyright © 2006, Ramesh Balasubramaniam

3

Table 1.

The American College of Rheumatology 1990 Criteria for the
Classification of FM * 1

1.

History of widespread pain
Definition. Pain is considered widespread when all of the following are
present: pain in the left side of the body, pain in the right side of the
body, pain above the waist, and pain below the waist. In addition, axial
skeletal pain (cervical spine or anterior chest or thoracic spine or low
back) must be present. In this definition, shoulder and buttock pain is
considered as pain for each involved side. “Low back” pain is
considered lower segment pain.

2.

Pain in 11 of 18 tender point sites on digital palpitation.
Definition. Pain, on digital palpitation, must be present in at least 11 of
the following 18 tender point sites:
Occiput: bilateral at the suboccipital muscle insertions,
Low cervical: bilateral, at the anterior aspects of the intertransverse
spaces at C5-C7.
Trapezius: bilateral, at the midpoint of the upper border.
Supraspinatus: bilateral, at origins, above the scapula spine near the
medial border.
Second rib: bilateral, at the second costochondral junctions, just lateral
to the junctions on the upper surfaces.
Lateral epicondyle: bilateral, 2 cm distal to the epicondyles.
Gluteal: bilateral, in upper outer quadrants of buttocks in anterior fold
of muscle.
Greater trochanter: bilateral, posterior to the trochanteric prominence.
Knee: bilateral, at the medial fat pad proximal to the joint line.

Digital palpitation should be performed with an approximate force of 4 kg.
For a tender point to be considered “positive” the subject must state that
the palpation was painful. “Tender” is not to be considered “painful.”
______________________________________________________________
*For classification purposes, patients will be said to have fibromyalgia if both
criteria are satisfied. Widespread pain must have been present for at least 3
months. The presence of a second clinical disorder does not exclude the
diagnosis of fibromyalgia.

4

Figure 1: Locations of FM tender points on the human body as defined by the
American College of Rheumatology 1990 criteria for the classification of FM 1

5

Table 2. Prevalence of frequently observed symptoms and signs in FM (% of
patients) 5
Widespread pain with tender points

100

Generalized weakness, myalgias, arthralgias

80

Nonrestorative sleep

80

Fatigue

70

Stiffness

60

Tension headache

53

Dysmenorrhea

40

Irritable colon, functional bowel disease

40

Subjective numbness, swelling, tingling

35

Livedo reticularis or skin hyperaemia

30

Complaints of fever

20

Complaints of swollen glands

20

Complaints of dry eyes

20

Subjective significant cognitive dysfunction

20

Significant psychopathology

5-20

Nocturnal myoclonus, restless leg syndrome

15

Female urethral syndrome

12

Vulvodynia or vaginismus

10

Concomitant reflex sympathetic dystrophy

6

5

Chapter 2. Purpose of the Study

The aim of the present study is to determine the presence of TMDs in FM
patients compared to failed back syndrome (FBS) patients. It is hypothesized that
FM patients will exhibit greater signs and symptoms of TMDs when compared to
FBS patients. It is also hypothesized that both FM and FBS patients will exhibit
significant psychosocial dysfunction.

Copyright © 2006, Ramesh Balasubramaniam
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Chapter 3. Review of the Literature

3.1. Temporomandibular Disorders
Temporomandibular Disorders is a subclassification of musculoskeletal
disorders that can cause pain in the orofacial region

12

. In the past, TMD was

considered a syndrome representing one disorder commonly referred to as
“TMJ,” but it is now considered a collective term representing various related
disorders of the masticatory system

8 12 22

. Pain originating from the masticatory

muscles or TMJs is the most common complaint and is frequently accompanied
by limited and/or asymmetric mandibular movement, and joint clicking and/or
crepitation 8.
To date, there is no universal known cause of TMD, although numerous
associative factors have been identified. It is likely that there is no one etiology
for TMD. Certain factors may affect the dynamic balance of the masticatory
system and increase the risk for dysfunction and pathology, rather than promote
ongoing adaptive physiologic health and function 23 8.

3.1.1 Prevalence of Temporomandibular Disorders
Prior to addressing the prevalence of TMD, it is important to recognize that
until recently there were essentially no evidence-based guidelines for the
diagnosis

and

classification

of

TMD.

The

available

cross-sectional

epidemiological studies were heterogeneous in TMD terminology, data collection

8

and interpretation of the variables studied 8.

Poor correlation between signs

(abnormal jaw movement, joint sounds, pain upon palpation) and symptoms
(face pain, joint pain) of TMD also led to questionable interpretation of their
clinical significance

17

. The standardization of TMD diagnoses was addressed by

the Research Diagnostic Criteria (RDC) committee with aims to improve the poor
quality of past epidemiology studies in TMD 24.
Okeson summarized the prevalence of commonly reported symptoms and
examined signs of TMDs based on 17 studies

12

. It was reported that signs and

symptoms of TMD are common in the general population. Report of at least one
TMD symptom ranged from 14% to 74%, and clinical findings of at least one
TMD sign ranged from 15% to 88%

25 26 27 28 29 30 31 32

33 34 35 36 37 38 39 40 41

.

Careful interpretation of these studies is pertinent as clinical signs are often
unknown to the patient and their relevance should be scrutinized

42

. As

previously mentioned, in spite of the high prevalence of TMD signs and
symptoms, various studies showed that the need for treatment ranged only
between 3.6-7%

13 14 15 16 9 17 18

. Although TMD symptoms requiring treatment

are uncommon complaints, TMD signs were found to increase with age in
children and young adults. In fact, TMD symptoms are more frequently reported
in patients between 20-40 years but not often in those who are older than 60
years

42 43 21 44 45 46

. This highlights the cyclic and rarely progressive nature of

TMD signs and symptoms

19 20 9 21

low overall prevalence of TMD

47

. It is also worth mentioning that in spite of the

, the societal cost as measured by yearly work

days lost is significant. It is reported that 17.8 million work days are lost each

9

year in the United States due to disabling TMD for every 100 million full-time
working adults 16.

3.1.2 Etiology and Pathophysiology of Temporomandibular Disorders
The etiology of TMD remains elusive which is partly due to its unknown
pathophysiology. The pathophysiology of TMD is multifactorial and varies
depending on the subclassification of TMD. For example, the pathophysiology of
masticatory myofascial pain is likely different than capsulitis of the TMJ 8.
Currently there are certain factors that are recognized as associated with
TMD but not necessarily causal. These factors may predispose, initiate and/or
perpetuate TMD under different circumstances

48 49 50

dynamic equilibrium of the masticatory system

23

. They may affect the

shifting it from an adaptive

physiologically healthy system to that of dysfunction and pathology. Although
speculative, the imbalance towards dysfunction and pathology is potentially
influenced by the psychological status of TMD patients

51

. The psychological

status of TMD patients will be discussed more extensively in the following
section.
The etiology of TMDs may be due to trauma, anatomic considerations,
pathophysiology and psychological issues. Trauma may be direct such as a blow
to the mandible, indirect such as acceleration-deceleration injury or microtrauma
such as clenching and grinding of teeth 8. Anatomic factors that are associated
with and may possibly represent TMD etiology may be divided into skeletal and
occlusal relationships. Skeletal factors include articular eminence steepness,

10

skeletal malformations and inter-arch and intra-arch discrepancies. Occlusal
factors include discrepancies between retruded contact and intercuspal position,
loss of molar support, extensive overbite, overjet and crossbite. The roles of
anatomic factors are currently believed to be less significantly associated with
TMD than previously thought and this will be explained under the TMD and
psychological issues section 8.
As previously mentioned, the pathophysiology of TMD is not currently
known but the speculations are numerous and varied. Factors may be systemic
such

as

degenerative,

endocrine,

infectious

and

rheumatologic.

Temporomandibular disorders secondary to pathophysiologic factors may include
FM as a systemic causative factor. On the other hand, local pathophysiologic
factors include synovial fluid viscosity, intracapsular pressure, and female
hormone levels 8.
As an illustration of the role of female hormones on TMD pathophysiology,
an increase in TMD pain was noted in women during lowest estrogen levels or
rapid estrogen change 52. It has been suggested that exogenous hormones in the
form of oral contraceptives may reduce fluctuations in estrogen during the
menstrual cycle. Therefore, exogenous hormones may be beneficial in chronic
TMD patients as they counteract estrogen depletion in late luteal and menses
phases of the menstrual cycles and avoid rapid estrogen changes experienced
during ovulation 53.
Psychological factors may affect the ability of TMD patients to cope with
difficult life situations. The relationship between psychological distress and

11

physiological consequences particularly has been established among TMD
patients with Post-traumatic Stress Disorder (PTSD) 54 55. It is to be determined if
psychological factors cause TMD or are the result of TMD or both. The following
section will discuss the relationship between TMD and psychological factors
more extensively 8.
In summary, regarding the pathophysiology and etiology of TMD, much
controversy remains. Many factors have been identified that may predispose,
initiate and/or perpetuate TMD. Further studies are needed to determine the
significance of these factors. It is likely that the relationship between
psychological distress and its physiological consequences will determine the
ability of the system to adapt versus to be prone to dysfunction and pathology.

3.1.3. Temporomandibular Disorders and Psychosocial Issues
The RDC for TMD involve two axes. Axis I is comprised of the physical
conditions of masticatory myofascial pain (MM) and/or TMJ pain. Axis II is
comprised of the psychological conditions and its effects in producing and/or
influencing the pain experience 24.
The link between TMD and psychological issues has been previously
established

56 57 58

. In contrast to healthy controls, TMD patients have higher

levels of depression and anxiety

59 51 60 61 62 63

. In addition, MM pain patients

frequently have more psychological issues compared to TMJ pain patients, with
elevated levels of depression, pain disability, and increased exposure to major
life stressors 64 65 66 55 67.

12

To further understand the link between TMD and psychological issues,
McEwen in 1998 proposed the allostatic load theory. The theory suggests longterm overactivity of the allostatic systems which are comprised of the autonomic
nervous, cardiovascular, metabolic, immune systems and hypothalamic-pituitaryadrenal (HPA) axis is detrimental in chronic pain

68

. It has been established that

the activity of the sympathetic portion of the autonomic nervous system is
increased by emotional stress. This is characterized by an increase in the arterial
blood pressure, blood flow to muscles, muscle activity, and mental activity,
commonly referred to as the “fight or flight” response

69

. Under acute stressful

conditions, this increased autonomic activity is favorable. However, persistent
chronic stressors, including major life events, may have long term consequences
on the person’s physical health

68

. It has been established that chronic emotional

stress can contribute to pain and can increase pain severity as a result of
overactive central nervous, autonomic and musculoskeletal systems

70

. Indeed,

chronic TMD patients demonstrate increased cardiovascular activity and altered
breathing rate compared to normal controls 63.
Thayer and Friedmann (2002)

71

described a self-organizing dynamic

system that governs the behavior of living systems. The ability of the system to
function efficiently when challenged by environmental demands is often
secondary to efficient inhibitory processes. The authors also suggested that the
process of sensitization is not always determined by overall hyperactivity. It may
be the result of a loss of inhibitory neural processes leading to maladaptive

13

activation of fewer brain pathways. Therefore, loss of inhibitory control may be
critical for efficient adaptability.
It is believed that the dysregulation of the HPA-axis may predispose
individuals for the development of chronic pain

72

, though neuroendocrinologic

investigations involving TMD have reported inconsistent findings. Jones et al
(1997) found that TMD patients had increased or typical levels of cortisol
released in response to stress compared to healthy controls

73

. On the contrary,

Venable (2003) reported hypocortisolism among TMD patients consistent with
findings of other stress-related disorders such as FM and chronic fatigue
syndrome

74

. However, Korszun et al (2002) in a study involving 15 female TMD

patients revealed hypercortisolism compared to a control group

75

. It seems

logical that cortisol levels may fluctuate with transient stressors, as demonstrated
by actual stress of venipuncture or anticipatory anxiety associated with
venipuncture

76

. In summary, chronic pain disorders, including TMD, are

potentially related to dysregulation of the HPA-axis.
As previously mentioned, the overall data

59 51 60 61 62 63 64 65 66 55 67

suggest TMD patients exhibit significant psychological dysfunction. A model
integrating the physical signs and symptoms and psychological distress in TMD
has been detailed

51

. Carlson et al (1998) studied and integrated the

psychological and physiological parameters of muscle pain TMD patients. This
study involved monitoring emotional and physiological responses (heart rate,
blood pressure, respiration, skin temperature, and muscle activity) of muscle pain
patients and age, sex and weight matched normal controls. Patients and controls

14

completed a series of questionnaires prior to a laboratory evaluation consisting of
a psychosocial stressor and pressure pain stimulation at multiple body sites. The
muscle pain patients reported greater fatigue, disturbed sleep, depression,
anxiety, menstrual symptoms and less self-deception than normal controls. In
addition, muscle pain patients had lower end tidal carbon dioxide levels and
lower diastolic blood pressures at rest than normal controls. The authors
suggested a central nervous system link between the physiology and psychology
in muscle pain TMD patients that affected their ability to recover physiologically
51

. Other studies have reported data from TMD patients that implicated altered

sensory pain experiences as a result of dysfunction in the modulatory controls of
the central nervous system

77 78

. This is further data concerning the role of a

dysfunctional central nervous system contributing to the pathophysiology of TMD.

3.1.4. Temporomandibular Disorders and Sleep Disturbance
There is a strong relationship between sleep and chronic pain

79 80 81 82

.

However, it is yet to be established whether chronic pains produce a sleep
disturbance or a sleep disturbance is significant in the instigation of chronic
pains. It has been suggested that progression of an acute muscle pain to a
chronic pain condition may be perpetuated by sleep disturbances

83

. In fact

stage-four deprivation led to musculoskeletal symptoms such as muscle
tenderness and stiffness in healthy patients, but such symptoms were not
observed following disruption of the rapid eye-movement (REM) sleep. This
suggests that poor sleep quality of the deeper sleep stages may be linked to

15

chronic pain conditions. The musculoskeletal symptoms are likely a consequence
of the failure to restore the metabolic functions of the body systems that occur in
deeper sleep stages
patients;

85

86

87

84

. Sleep disturbances are common complaints of TMD

with higher preponderance among muscle pain patients

compared to TMJ pain patients 66 88.

3.1.5. Summary
From the aforementioned review it is apparent that a more precise
prevalence of TMD is yet to be determined. This is due to previous studies
having heterogeneous TMD terminology, varied data collection strategies and
differences in interpretation of the variables. Likewise, TMD pathophysiology and
etiology is yet to be determined, although numerous associated factors have
been identified. The relationship between TMD and psychosocial issues is
established but its impact also remains to be determined. It has been proposed
that dysregulation of the HPA-axis and autonomic nervous system as well as loss
of inhibitory neural modulation are associated with TMD as well as other chronic
pain conditions.

16

3.2. Fibromyalgia
Sir Edward Gowers coined the term fibrositis (old term for FM) to further
classify lumbago in the early 20th century

89

. However, Smythe and Moldofsky

first recognized the consistent palpable soft tissue tender points associated with
widespread pain of fibrositis

90

. Since that time, there has been much debate on

the credibility of persons presenting with signs and symptoms of a generalized
musculoskeletal system pain consistent with FM. The financial burden these
patients pose on governments and insurance companies is significant

91 92 93

.

This motivated, in part, the development of the FM classification criteria in 1990
by the ACR, which are now used throughout the world for investigating this
enigmatic condition 1. In spite of ongoing criticism of the subjective nature of FM
complaints, the classification is moderately sensitive (88.4%) and specific
(81.1%) and hence useful for distinguishing FM from other chronic pain
syndromes 1. Physical findings of FM are based on palpation pressure of 4
kilograms resulting in pain in at least 11 of the potential 18 tender points
including skeletal muscles, ligaments and bursae. Pain upon palpation felt in
these tender points is thought to represent allodynia. For details of the
classification, see Table 1 and Figure 1.
The prevalence of FM in the adult population is estimated to be 2% (0.5%
males and 1.5% females) with the highest prevalence being in women between
the age of 50-60 years

1 94

. It has been reported that 6-10% of patients in a

physician’s waiting room meet the classification criteria for FM

95

. FM patients

typically describe their pain as persistent, diffuse, deep, aching, throbbing, and/or
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stabbing pain associated with dysesthesia. Apart from the obvious reporting of
pain and associated typical tender points, FM patients commonly present with
symptoms of anxiety, depression, sleep disturbances, dizziness, morning
stiffness, physical fatigue, IBS and interstitial cystitis 96 (Table 2). The comorbidity
of FM with other conditions such as chronic fatigue syndrome, IBS, TMD, chronic
headaches and interstitial cystitis may be related to a reduction in pain threshold
and tolerance mediated by central nervous system mechanisms. In addition,
these conditions are marked by a heightened sensitivity to both physical and
psychological stress 96 97 7 98 99.

3.2.1 Etiology and Pathophysiology of Fibromyalgia
The etiology of FM is not known. An autosomal dominant inheritance for
FM has been reported but no gene abnormalities have been identified

100

.

Histologic and electromicroscopic studies have failed to discover skeletal muscle
abnormalities 101.
The preponderance of females with FM may provide some insight to the
pathophysiology of FM. Epidemiology studies have revealed a lower pain
threshold for females compared to males in healthy populations

94 102

. This may

be explained by the lower levels of 5-hydroxytryptophan (5-HT) synthesis and
metabolism. A radiology study involving CNS positron emission tomography
revealed lower conversion rate of methylated analog of 5-HT to 5-hydroxyindole
acetic acid among healthy adult females. These data suggest a gender-related
difference in antinociceptive activity. Interestingly, in spite of a large female
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preponderance for FM, a relationship between FM and circulatory sex hormones
has not been established 103 104.
FM patients may present with neuroendocrine dysfunction involving the
HPA-axis, the sympatho-adrenal system, the hypothalamus-pituitary-thyroid axis
or the hypothalamic-pituitary-growth hormone axis

105 106 107 108

. It has been

suggested that abnormalities in serotonin and norepinephrine availability in the
CNS may explain the neuroendocrine dysfunction 109. Studies have also revealed
lower adenosine triphosphate (ATP) levels in the red blood cells of FM patients
110 111

and this may explain low levels of platelet serotonin since ATP is required

for serotonin platelet binding and uptake.
One third of FM patients had a drop in blood pressure, some with
episodes of syncope, when undergoing tilt-table testing suggesting an autonomic
nervous system dysfunction

112

. Studies on diurnal heart rate variability among

FM patients revealed sustained sympathetic tone at night

113

. A sustained

dysfunctional sympathetic tone may be due to a loss of inhibitory neural
pathways leading to maladaption

114 71

. These findings suggest that like TMDs,

FM patients experience a loss of inhibitory control.
Serum studies of FM show abnormal biochemical levels of tryptophan,
serotonin, substance P

96

, and growth hormone. Dysregulation of diurnal cortisol

production has also been documented

106

. These neurochemical abnormalities

may suggest a facilitation or failure in inhibition of nociception leading to central
sensitization and increased pain perception. They may affect the dynamic
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equilibrium of the system that shifts it from an adaptive physiologically healthy
system to that of dysfunction and pathology 114 71.
Taken together, the pathophysiology and etiology of FM remain unknown.
However, much progress has been made in understanding factors associated
with the syndrome. The old school of thought whereby FM patients were once
considered depressed somatizers is now considered unlikely. Abnormal CNS
neurochemicals such low 5-HT and high substance P are more likely
explanations of the pain amplification represented in FM.

3.2.2. Fibromyalgia and Psychosocial Issues
As previously discussed, the pathophysiology of FM remains an enigma. It
has been reported that FM may merely represent somatic manifestations of an
affective disorder, further supported by the lack of an objective measure of this
syndrome

115

. Interestingly, rheumatoid arthritis (RA) was also once considered

an affective disorder

116 117

. Studies involving RA and FM reported FM patients

as having higher scores compared to RA patients for hypochondriasis, hysteria,
psychotic behavior, paranoia, and schizophrenia as measured by the Minnesota
Multiphasic Personality Inventory (MMPI)

118

. Similarly, another study reported

that FM patients had a 70% lifetime rate of major affective disorder compared to
13% among RA patients. Of the FM patients with major depression, 64%
reported the onset of affective symptoms occurring at least one year after the
diagnosis of FM. This suggests that FM patients are depressed as a result of
their somatic symptoms, rather than that major depression resulted in somatic
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manifestations. However, this study also revealed that 10% of 1st degree
relatives of FM patients were depressed compared to only 3% of the RA patients
115

.
It is has been established by various studies that depression does exist

among FM patients but whether it is significantly more prevalent among FM
patients compared to other chronic pain patients remains controversial. Some
studies suggest that FM patients are more depressed than RA patients

4 119

whereas others suggest that although depression may exist, there is no
difference in the prevalence of depression among the two groups of patients
121 122 123

120

. It is likely that the presence of depression and anxiety may amplify the

pain and fatigue experienced by FM patients 124. The reverse outcome is likely as
well, whereby affective symptoms may be the result of chronic pain, fatigue,
sleep disturbances and a reduced quality of life.

3.2.3 Fibromyalgia and Sleep Disturbances
FM patients frequently complain of disturbed, non-refreshing sleep

96 1

. It

has been suggested that increased pain in FM patients may contribute to sleep
disturbances and sleep disturbances may result in increased pain in FM patients
79

. Polysomnographic studies have reported intrusion of alpha frequency

electroencephalogram during non-rapid eye movement sleep among FM patients
125

126

. Interestingly, FM-like symptoms may be associated with sleep

disturbances in healthy patients

127

. Whether sleep disturbances have a role in

the pathophysiology of FM is to be determined.
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3.2.4 Summary
From the above mentioned review, it is apparent that FM remains a
perplexing

condition.

Further

studies

on

its

prevalence,

etiology

and

pathophysiology are pertinent as it may improve existing treatment strategies and
motivate research for newer treatments. The key to deciphering this difficult
condition probably lies in understanding the role of autonomic nervous system
dysfunction and loss of inhibitory neural modulation.

3.3. Temporomandibular Disorders and Fibromyalgia
Numerous studies in the past have suggested relationships between FM
and TMD 128 129 130 131 132 133 134. The conclusions drawn from these studies seem
logical based on the definition of FM as a form of non-articular rheumatism
characterized by widespread muscle pain, tenderness to palpation and stiffness
of the locomotor system

94

. It seems reasonable that FM may encompass TMD,

which is a collective term embracing a number of clinical problems that involve
the masticatory musculature, the TMJ and associated structures 8.
Hedenberg-Magnusson et al (1999) suggested that FM is a cause of TMD.
The authors investigated TMD symptoms based on a questionnaire completed by
a large sample of FM patients. Ninety-four percent of these patients described
TMD pain which reportedly followed pre-existing FM pain of long duration.
Patients also reported headache, facial pain, jaw fatigue and difficulty chewing
and opening the mouth

128

. Because of subjective reporting of TMD symptoms,

the conclusion that FM causes TMD should be cautiously considered since
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objective clinical findings were not performed and the design does not allow
inference of comorbidity. FM and TMD share common symptoms such as
generalized pain sensitivity, sleep and concentration difficulties and headaches
135

which may influence symptom reporting.
Plesh et al (1996) investigated prevalence and symptom severity of both

FM and TMD among FM and TMD patients using the ACR and RDC for TMD
criteria respectively. They concluded that these are separate disorders; however,
FM patients commonly reported TMD symptoms but it was rarely the case that
TMD patients reported FM

129

. Eighteen percent of TMD patients fulfilled the FM

criteria, whereas 75% of FM patients met the criteria for TMD. This study also
revealed that FM patients had lower pain thresholds with more frequent and
more severe symptoms such as pain, sleep disturbances, and fatigue than TMD
patients. In addition, FM patients reported more functional disability, work
difficulty and overall health dissatisfaction

129

. In support of the study by Plesh et

al (1996), Pennacchio et al (1998) revealed that 97% of FM patients had signs
and symptoms of TMD. These signs and symptoms included pain or tenderness
of the masseters, temporalis and TMJs, history of trauma, facial asymmetry,
bruxism and limited range of mandibular movement. Contrary to the study by
Plesh et al. (1996), Pennacchio et al. (1998) found that the type, intensity,
description and quality of pain were similar in both TMD and FM patients
Therefore, it was suggested that FM and TMD share common symptoms

135

136

.

. The

extent of the relationship between FM and TMD based on these common
symptoms needs to be studied further.
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Cimino et al. (1998) compared clinical and psychological features of FM
and masticatory myofascial pain syndrome patients. Clinical findings of muscle
palpation did not reveal any difference between the two groups, nor were there
differences in active and passive mouth opening. Similarly, both groups had
elevations in psychological distress scores but there were no significant
differences between the groups 137.
Comorbidity between myofascial pain (myalgia) of FM and TMD has been
reported as well. In a study by Dao et al. (1997) which included myogenous
TMD patients, many patients had pains in various body sites. Similarly, FM
patients exhibited comparable facial pain to that of TMD patients. The authors
suggested that FM should be a differential diagnosis for TMD patients with
primary muscle complaints. In spite of these observations, FM was considered
far more debilitating with respect to number of pain sites, somatic symptoms and
level of pain intensity than was TMD. The authors suggested that TMD and FM
are distinct clinical disorders

138

. In addition, it was suggested that the presence

of facial pain may be due to a decrease in pain threshold associated with FM, as
proposed by Wolfe 94 138.
According to Rhodus et al (2003), the prevalence of TMD based on a
questionnaire among FM patients was 67.6% compared to 20% among controls.
In addition, 60% of FM patients were depressed and anxious but this was not
statistically different from controls with TMD

99

. This was confirmed by an earlier

study that reported presence of psychopathological profiles for depression and
anxiety among FM patients and TMD patients 139.
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The above studies imply a relationship between TMD and FM. However,
the relationship is unclear as many of the studies were retrospective or
observational, not blinded, uncontrolled, questionnaire based and, most often,
had small sample sizes. Similarly, some of the studies did not use the ACR
classification for FM and many studies did not define TMD or failed to use the
RDC for TMD classification. If a clear relationship does exist between FM and
TMD, it is likely related to the dysregulation of the HPA axis and dysfunction of
the autonomic nervous system, as well as the disturbances in peripheral and
central inhibitory control mechanisms 97 140.

3.3.1. Summary
This review highlights a relationship between FM and TMD. Although
many uncertainties exist, signs and symptoms of TMD may be present in FM
patients. It is therefore not unlikely that FM may be an etiologic factor for TMD.
Based on these previous findings, this study will examine the presence of signs
and symptoms of TMD in FM patients compared to failed back syndrome (FBS)
patients as well as evaluate the differences in psychosocial distress.

Copyright © 2006, Ramesh Balasubramaniam
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Chapter 4. Experimental Design and Methods
4.1. Participants
This was a prospective study that involved recruiting patients visiting the
Physical Medicine and Rehabilitation Clinic and patients from a FM workshop
organized by the Center for the Advancement of Women’s Health at the
University of Kentucky between March 2005 and April 2006. The research was
approved by the Institutional Review Board for the Protection of Human Patients.
The study sample included 32 FM and 19 FBS patients. The FM patients for the
study had received a diagnosis by a physical medicine and rehabilitation
specialist or rheumatologist, based on the criteria for the classification of FM as
established by the ACR

94

. The diagnosis of FBS was based on persistent or

recurrent, chronic lower back pain after at least one failed surgical procedure of
the lumbasacral spine

141 142 143

. All interested patients were required to sign an

informed consent and were compensated $20 for their time.

4.2. Inclusion and Exclusion Criteria
Patients who presented with the following characteristics were included in
the study:
1. At least 18 years of age.
2. A primary diagnosis of FM or FBS.
3. Pain duration of at least 6 months.
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Patients who presented with the following characteristics were excluded
from the study:
1. Other chronic pains unrelated to the primary diagnosis.
2. Uncontrolled metabolic diseases (e.g uncontrolled diabetes).
3. Neurological disorders (e.g trigeminal neuralgia).
4. Uncontrolled vascular diseases (e.g. uncontrolled hypertension).
5. Neoplasia.
6. Current psychiatric treatment.

4.3. Questionnaires
Prior to the examination, all patients were given an orofacial pain
questionnaire and a battery of psychological assessments. The orofacial pain
questionnaire included questions about the patient’s orofacial complaints and
medical history. The psychological questionnaires included the Symptom Check
List-90-revised (SCL-90-R)

144

, the Pittsburgh Sleep Quality Index (PSQI)

the Multi-dimensional Pain Inventory (MPI)
Disorder Checklist-Civilian Version (PCL-C)

146

147

145

,

, the Post-traumatic Stress

, and Multidimensional Fatigue

Symptoms Inventory-short form (MFSI-SF) 148.

4.3.1. Orofacial Pain Questionnaire
All patients completed this questionnaire which gathered demographic
data, presence of face or headache pain, and medical history. Patients with
current face pain were required to provide details on its location, onset, severity,
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quality, and aggravating and ameliorating factors. Presence of mouth pain,
headache, and TMJ sounds and dysfunction were also solicited. Disability or
intentions to seek disability was also established.
In

addition,

the

orofacial

pain

questionnaire

included

qualitative

descriptors from the McGill Pain Questionnaire for self-report of the pain
experience

149

. These characterizations of pain are divided into sensory and

affective classifications. The sensory category included terms such as throbbing,
shooting, stabbing, and aching, while the affective category contained terms such
as sickening, exhausting, and punishing (Appendix 1).

4.3.2 Psychometric Measures
The psychological questionnaires included the SCL-90-R

144

, the PSQI

145

the MPI 146, PCL-C 147, and MFSI-SF 148.
The SCL-90-R

144

was used to assess current psychological symptom

status of the patients on nine dimensions. These dimensions include:
somatization,
depression,

obsessive-compulsive
anxiety,

psychoticism.

hostility,

behavior,

phobic

anxiety,

interpersonal
paranoid

sensitivity,

ideation,

and

It consists of a 90-item multi-dimensional self-report inventory

which is scored on a five-point scale of distress (0-4). A subscale score ≥63 was
deemed clinically significant. Test-retest reliabilities range from r = 0.78 to 0.90
for non-patient samples, and internal consistencies range from 0.77 to 0.90 144.
The MPI

146

was used to determine pain severity, as well as to provide a

pain profile classification of each subject. It included three sections and contains
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61 questions. The MPI pain profile classification is based on pain level, social
and physical activities, affective distress, social support, and feelings of life
control. Test-retest reliabilities of the individual scale scores range from r = 0.68
to 0.86, and internal consistencies range from 0.73 to 0.90

146

. Patients were

classified into three prototypic profiles namely dysfunctional, interpersonally
distressed and adaptive copers. Patients who report a high level of pain, distress,
and disability and who feel pessimistic and helpless about their condition are
classified as dysfunctional. The interpersonally distressed category includes
patients with the same characteristics as dysfunctional and in addition report
poor social support. Patients who report low levels of pain, disability, and distress
are classified as adaptive copers. Other classification categories include hybrid,
anomalous and unanalyzable profiles. The hybrid profile represents a
combination of prototypic profiles. The anomalous profile classification was used
when no sense can be made of the MPI scale scores to establish a particular
theory. Random responding, reading or responding difficulties, or faking bad or
good responses contributes to allocation of the anomalous profile. When data are
missing and statistical analyses of the scores are not possible the unanalyzable
profile is allocated.
The PSQI

145

was used to gather information regarding the amount of

hours the subject sleeps each night, the amount of hours in bed each night, how
often the subject is awakened and why, as well as how difficult it is for the subject
to return to sleep upon awakening. A PSQI total score of > 5 categorized
subjects as poor sleepers. The PSQI has exhibited test-retest stability (full scale r
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= 0.85), good overall internal consistency (α = 0.83), and provides a valid and
reliable assessment of overall sleep quality and disturbance 145 150.
The PCL-C instrument includes 15 itemized statements about
significant traumatic stressors that the subject may have experienced. The items
listed include: military combat, violent attack, being kidnapped, taken hostage,
terrorist attack, torture, incarceration, natural or man-made disaster, severe auto
accident, being diagnosed with a life-threatening illness, sudden injury/serious
accident, observed someone hurt or killed, learning that her/his child has a lifethreatening illness, and an others category. Subsequently, the subject is asked to
identify the most significant stressor, indicate the date of occurrence and
appraise how much the most significant stressor has bothered her/him in the past
month on the 17-item measure. These questions are graded from 1 (not at all) to
5 (extremely) to indicate the impact of the most significant traumatic stressor.
Based on the subject’s answers a likely diagnosis of PTSD may be ascertained
according to the DSM-IV. A cut-off score of ≥41 on the 17-item measure was
deemed as PTSD positive and a score of <41 was deemed PTSD negative. The
PCL-C has exhibited sensitivity = 0.85, specificity = 0.90, positive predictive
power = 74%, negative predictive power = 95%, test-retest stability (r = 0.96),
good overall internal consistency (alpha = 0.92), and provides a valid and reliable
assessment of the presence of PTSD symptoms 151 147.
The MFSI-SF identifies 5 facets of fatigue: 1) global experience of fatigue;
2) somatic symptoms of fatigue; 3) cognitive symptoms of fatigue; 4) affective
symptoms of fatigue; and 5) behavioral symptoms of fatigue
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148

. Each facet is

calculated from the mean of six sub-scores of fatigue-related symptoms. The
shortened version (MFSI-SF) which consists of 30 statements was used for this
study. Patients were asked to rate each statement according to how true it has
been for them over the past 7 days along a 5-point scale (0 = not at all; 4 =
extremely). There are no formal reliability and internal consistency data for this
assessment. However, de Leeuw et al. (2005) reported high overall internal
consistency for each of the subscales (.88 < alpha < 0.96) using a TMD patient
population and age and sex healthy controls 152.

4.4 Clinical Examination
The orofacial pain examination involved a thorough clinical assessment by
a dentist who was blinded to the clinical diagnosis of the patients. The dentist
was unaware with regard to whether he examined a FBS or FM subject. The
clinical examination was carried out using a modified version of the examination
protocol that has been used at the University of Kentucky, Orofacial Pain Center
for many years (Appendix 2). The dentist was trained at the Orofacial Pain
Center and had performed numerous similar clinical examinations. Based on the
clinical data and according to the RDC for TMD, a list of prioritized diagnoses
were made

24

. These diagnoses were verified by two other dentists trained at the

University of Kentucky, Orofacial Pain Center. If there was a disagreement
between the two dentists as to the RDC diagnoses for TMDs, a discussion was
held among the three dentists and consensus as to the appropriate diagnoses
was reached.
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4.5 Statistical Analyses
The analyses of the data involved comparing the FM and FBS patients.
The sociodemographic data, namely age, was tested using the Student’s t-test.
Gender, education, marital status, and smoking were tested using Fisher’s exact
test, and employment and disability were tested using the Chi-square test.
Comparison of the presence of orofacial pains between FM and FBS
patients involved statistical analyses using SAS 9.1 (SAS Institute Inc.) namely
the two sample t tests comparing mean scores between the two groups, or Chisquare / Fisher’s Exact tests comparing the outcome percentages between the
two groups were conducted. For the binary outcomes, odds ratio and 95%
confidence interval of the odds ratio were calculated. In addition, further analysis
for the comparison of the percent of patients meeting RDC for TMD criteria
between patients who reported face pain and those who did not was tested using
the Fisher’s Exact test and Chi-square test.
Comparison of pain severity and pain duration between FM and FBS
patients who reported face pain were tested using the two sample t-test.
Similarly, comparison of SCL-90-R symptoms dimensions, MPI categories,
MFSI-SF and PSQI scores between FM and FBS patients were also tested using
the two sample t-test. Frequency of MPI profile classification among FM and FBS
patients was tested using Fisher’s exact test and the Chi-square test.
Comparison of the percentage of patients who reported a stressful life event and
those who met the PTSD criteria between FM and FBS patients was tested using
Fisher’s exact test. Pearson’s correlation was performed to determine
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correlations between sleep disturbances and fatigue-related symptoms among
FM and FBS patients. Significance level for all comparisons was set at P=.05.
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Chapter 5. Results

5.1 Sample size, Sociodemographic Characteristics, Prevalence, Severity
and Duration of Temporomandibular Disorders
The total sample was comprised of 51 adult patients (male = 6; female =
45). The FM group comprised of 32 patients (male = 0; female = 32) with a mean
age of 52.2 ± 7.8 years. The FM group (P=0.002) differed with respect to gender
from the FBS group which comprised of 19 patients (male = 6; female = 13) with
a mean age of 50.0 ± 9.1 years. The two groups also differed with respect to their
education level (P=0.03), where a greater number of FM (40.5%) patients had
college degrees in comparison to FBS (21%) patients. Tobacco use was
significantly more prevalent among the FBS (42%) compared to FM (3%)
patients (P<0.0001). There were no significant differences between the two
groups in regard to age (P=0.36), marital status (P=0.60), employment (P=0.55),
and disability (P=0.48; see table 3).
Fifty three percent of the FM patients reported face pain compared to the
11% of the FBS group (p=0.002). The FM patients were 9.6 times more likely to
report face pain than the FBS group. The FM patients also reported a greater
prevalence of headache (78%) compared to the FBS patients (63%) but this
difference was not statistically significant (P=0.25). Almost the same percentage
of FBS patients (42%) and FM patients (41%) reported mouth pain (see table 4).
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Of the FM patients who reported face pain, 71% fulfilled the clinical RDC
for TMD criteria. Of those FM patients who did not report face pain, 47% fulfilled
the clinical RDC for TMD criteria. However, within the FM group, the patients who
reported face pain were not significantly more likely to meet clinical RDC for TMD
criteria compared to the patients who did not report face pain (P=0.17, odds
ratio=2.74, 95%C.I.=0.64-11.75). Also, within the FBS group, the patients who
reported face pain (50%) were not significantly more likely to meet the clinical
RDC for TMD criteria compared to the patients who did not report face pain
(12%) (P=0.30, odds ratio=7.5, 95%C.I.=0.32-173.28; see table 5).
.

The various RDC for TMD diagnostic subcategories were allocated for
both FM and FBS patients. No significant difference was found for any of the
diagnostic subcategories between the two groups (P > 0.05; see table 6).
Seventy four percent of the FM patients received a muscle diagnosis which
included 32% myofascial pain and 42% myofascial pain with limited opening.
Two out of the three FMS patients who met the RDC criteria for TMD received a
muscle diagnosis and these two patients were diagnosed with myofascial pain
with limited opening (66%). Twenty one percent of the FM patients were
diagnosed with a disk displacement with reduction and this included any
participant having internal derangements in either or both joints. Arthralgia was
diagnosed in 16%, TMJ osteoarthritis in 26% and TMJ osteoarthrosis in 37% of
the FM patients.
Pain severity was measured based on a 0-10 visual analogue scale and
reported as 5.2 ± 2.1 and 3.5 ± 0.7 for the FM and FBS patients respectively.
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Pain duration was calculated to be the time in months from when the pain began
through to the examination. Pain duration reported by patients was 50.3 ± 117.2
and 53.5 ± 72.8 months for the FM and FBS patients respectively. No significant
differences were found for mean pain severity and mean pain duration between
FM and FBS patients (see table 7).

5.2 Psychometric Data
5.2.1 Symptom Check List-90-Revised
Analyses of SCL-90-R data revealed numerically higher scores on all
subscales for FM as compared to FBS patients, although these differences were
not statistically significant for most scales (see table 8). The FM patients had
statistically significant higher scores for somatization (P=0.02) and obsessivecompulsive (P=0.009) subscales compared to the FBS patients. The FM patients
had clinically relevant subscale scores for somatization, obsessive-compulsive
and depression, whereas the FBS patients had a clinically relevant subscale
score for somatization.

5.2.2 Multidimensional Pain Inventory Profile Classification
The FM patients had numerically higher scores on “pain severity”,
“interference”, “affective distress”, “punishing responses”, “household chores”,
“outdoor work”, and “activities away from home” scales and had lower scores on
“life control”, “support”, “soliciting responses”, “distracting responses”, “social
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activities”, and “general activities level” scales than the FBS patients. However,
these differences were not statistically significant (P>0.05; see table 9).
When possible, patients were classified in one of the three main MPI
profiles. Twenty five percent of the FM patients were classified as “dysfunctional”,
31% were classified as “interpersonally distressed” and 28% were classified as
“adaptive copers”. No significant differences (P>0.05) were found between the
FM patients and the FBS patients with regard to the MPI main profile
classification (see table 10).

5.2.3 Pittsburgh Sleep Quality Index
Both FM and FBS patients had elevated PSQI total scores suggesting
poor sleep but there was no significant difference between the two groups. The
mean score for “use of sleep medication” was significantly different between the
FM and FBS patients (P=0.002) whereby the FM patients had a higher score for
sleep medication use than the FBS patients. None of the other PSQI scales
showed significant differences between the FM and FBS groups (see table 11).

5.2.4 Post-traumatic Stress Disorder Checklist- Civilian Version
There were significant differences between the FM and FBS groups in the
percentage of patients reporting a stressful life event (P=0.04, odds ratio=5.2,
95% C.I.=1.28-21.18). Eighty seven percent of FM patients reported a stressful
life event compared to 56% of FBS patients. FM patients were 5.2 times more
likely to report a stressful life event compared to FBS patients (see table 12).
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Of the FM patients who reported a stressful life event, 42.3% were
deemed PTSD positive compared to 30% of the FBS patients. However, there
was no statistical evidence that FM patients were more likely to have PTSD
positive symptoms than FBS patients (P=0.71, odds ratio=1.71, 95% C.I.=0.368.15) (see table 13).

5.2.5 Multidimensional Fatigue Symptoms Inventory-short form
FM patients had significantly higher general fatigue (P<0.0001), emotional
fatigue (P=0.008), physical fatigue (P<0.0001) and mental fatigue (P<0.0001)
than FBS patients. The FBS patients had a higher vigor score than the FM
patients but this difference was not statistically significant (see table 14).
It appears that among the FBS patients the PSQI total score, sleep
latency, sleep duration, sleep efficiency, sleep disturbances, and daytime sleep
dysfunction are correlated with one ore more fatigue related symptoms (P<0.05;
see table 15). Among FM patients, it appears that the PSQI total score,
subjective sleep quality, sleep latency, sleep duration and sleep efficiency are
correlated with one or more fatigue related symptoms (P<0.05; see table 16).
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Table 3: Comparison of Sociodemographic Characteristics between FM
and FBS Patients.
FM (n=32)
FBS (n=19)
P
n (%)
n (%)
Age a
Mean±SD
52.2±7.8
50.0±9.1
0.36
Range
35-72
34-65
Gender b
Male
Female

0 (0%)
32 (100%)

6 (32%)
13 (68%)

Marital Status b
Single
Married
Divorced
Widowed

4 (12.5%)
24 (75%)
4 (12.5%)
0 (0%)

3 (16%)
12 (63%)
3 (16%)
1 (5%)

Employed c
Yes
No
Education b
High school
Associate or Technical
BS/BA
Graduate Degree or
Professional Degree
None of the Above
Disability c
Yes
No

0.002*

0.60

0.55
11 (34%)
21 (66%)

5 (26%)
14 (74%)

14 (44%)
5 (16%)
9 (28%)
4 (12.5%)

8 (42%)
5 (26%)
0 (0%)
4 (21%)

0 (0%)

2 (11%)

0.03*

0.48
17 (53%)
15 (47%)

Tobacco Use b
Yes
1 (3%)
No
31 (97%)
a
t test assuming unequal variance
b
Fisher’s exact test
c
Chi-square test
n=number of patients
%=percentage
SD=standard deviation
* Statistical significant difference
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12 (63%)
7 (37%)
<0.0001*
8 (42%)
11 (58%)

Table 4: Comparison of Presence of Orofacial Pains between FM and FBS Patients.
Odds Ratio of FM vs.
Outcome
FM
FBS
P+
FBS (95% C.I.)
(n=32)
(n=19)
n (%)
n (%)
Reported Face Pain
0.002* 9.6 (1.9-48.7)
Yes
17 (53%) 2 (11%)
No
15 (47%) 17 (89%)
Reported Mouth
Pain
Yes
No

13 (41%)
19 (59%)

Reported Headache
Yes
25 (78%)
No
7 (22%)
* Statistical significant difference
+
Chi-square test
%=Percentage

0.92

0.94 (0.30-3.0)

0.25

2.1 (0.6-7.3)

8 (42%)
11 (58%)
12 (63%)
7 (37%)
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Table 5: Comparison of FM and FBS Patients who Reported Face Pain to
those who did not Report Face Pain (for patients who met the Clinical RDC
for TMD Criteria).
Group
Outcome
Reported Did Not
P
Face
Report Face
Pain
Pain
n (%)
N (%)
FM
Met RDC for TMD
0.17
Criteria a, b
(n=32)
Yes
12 (71%) 7 (47%)
No
5 (29%)
8 (53%)

Odds Ratio
(95% C.I.)
2.7 (0.611.8)

0.30 7.5 (0.3Met RDC for TMD
c
173.3)
Criteria or Not
(n=19)
Yes
1 (50%)
2 (12%)
No
1 (50%)
15 (88%)
a
pertains to the clinical findings that fulfilled the RDC for TMD criteria
b
Chi-square test
c
Fisher’s exact test
n=number of patients
%=percent
FBS
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Table 6: Comparison of TMD Diagnoses between FM and FBS Patients (for
Patients who met Clinical RDC for TMD)
TMD Diagnosis
FM
FBS
P*
Odds Ratio
(n=19)
(n=3)
(95% C.I.)
Myofascial Pain b
0.53
NA
Yes
6 (32%)
0 (0%)
No
13 (69%) 3 (100%)
Myofascial Pain With Limited
Opening b
Yes
No

8 (42%)
11 (58%)

b

Disk Displacement Without
Reduction, With Limited Opening b
Yes
No
Disk Displacement Without
Reduction, Without Limited
Opening b
Yes
No
Arthralgia b
Yes
No
Osteoarthritis of the
Temporomandibular Joint b
Yes
No
Osteoarthrosis of the
Temporomandibular Joint b
Yes
No
* Fisher’s exact test

4 (21%)
15 (80%)

0 (0%)
19
(100%)

0 (0%)
19
(100%)
3 (16%)
16 (84%)

5 (26%)
14 (74%)

7 (37%)
12 (63%)
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0.36 (0.03-4.7)

1.00

NA

1.00

NA

1.00

NA

0.47

0.38 (0.03-5.8)

1.00

NA

1.00

1.2 (0.09-15.3)

2 (67%)
1 (33%)

Disk Displacement With Reduction
Yes
No

0.57

0 (0%)
3 (100%)

0 (0%)
3 (100%)

0 (0%)
3 (100%)

1 (33%)
2 (67%)

0 (0%)
3 (100%)

1 (33%)
2 (67%)

NA=not available due to zero frequencies
n=number of patients
%=percentage
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Table 7: Comparison of Pain Severity and Pain Duration between FM and FBS Patients
who Reported Face Pain.
Outcome
Group
n
Mean
SD
P*
Pain Severity (0-10)
FM
17
5.2
2.1
0.29
FBS
2
3.5
0.7
Pain Duration
(Month)

FM

17

50.3

117.2

FBS

2

53.5

72.8

* two sample t test
n=number of patients
SD=standard deviation
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0.97

Table 8: Comparison of SCL-90-R Symptom Dimensions between FM and FBS
Patients.
SCL-90-R
Group
n
Mean
SD
P+
Symptom
Dimensions
Somatization

FM
FBS

31
19

70.5
65.0

7.9
8.2

0.02*

ObsessiveCompulsive

FM

31

69.7

10.4

0.0009*

FBS

19

60.1

8.6

FM

31

60.8

9.8

FBS

19

54.1

14.2

Depression

FM
FBS

31
19

64.4
61.8

9.0
10.8

0.37

Anxiety

FM
FBS

31
19

61.3
56.4

11.6
13.1

0.17

Hostility

FM
FBS

31
19

56.6
53.1

10.9
12.0

0.30

Phobic Anxiety

FM
FBS

31
19

55.2
53.7

12.1
8.1

0.63

Paranoid Ideation

FM
FBS

31
19

56.6
53.5

12.0
11.4

0.36

Psychoticism

FM
FBS

31
19

60.0
58.9

10.9
8.6

0.72

Interpersonal
Sensitivity

+

two sample t test
n=number of patients
SD=standard deviation
* Statistically significant difference
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0.052

Table 9: Comparison of MPI Categories between FM and FBS Patients.
MPI Scale
Group
n
Mean
SD
Part I
Pain Severity

P*

FM
FBS

32
19

46.0
39.5

11.1
14.9

0.08

Interference

FM
FBS

32
19

46.7
44.4

10.3
12.5

0.47

Life Control

FM
FBS

32
19

49.3
52.2

7.0
8.3

0.19

Affective Distress

FM
FBS

32
19

46.9
42.0

7.6
10.5

0.059

Support

FM
FBS

29
18

43.6
46.7

10.1
8.4

0.29

FM
FBS

30
18

51.4
46.2

10.2
7.0

0.065

Soliciting Responses

FM
FBS

30
18

48.2
52.6

10.1
7.4

0.11

Distracting Responses

FM
FBS

30
18

45.4
47.8

8.8
7.3

0.33

FM
FBS

32
19

54.8
51.1

10.0
8.4

0.17

FM
FBS

32
19

51.5
47.4

8.3
7.6

0.09

FM

32

50.9

9.7

0.63

FBS

19

49.6

8.2

Social Activities

FM
FBS

32
19

45.0
47.3

9.8
6.0

0.32

General Activity Level

FM
FBS

32
19

51.3
48.7

8.7
8.1

0.30

Part II
Punishing Responses

Part III
Household Chores
Outdoor Work
Activities Away From
Home

46

* two sample t test
n=number of patients
SD=standard deviation
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Table 10: Comparison of MPI Profile Classification between FM and FBS
Patients.
MPI Classes
FM
FBS
P
Odds Ratio
(n=32)
(n=19)
(95% C.I.)
Dysfunctional c
Yes
No
Interpersonally
Distressed b
Yes
No
Adaptive Coper c
Yes
No
b
Fisher’s exact test.
c
Chi-square test.
N=number of patients
%=percentage

8 (25%)
24 (75%)

10 (31%)
22 (69%)
9 (28%)
23 (72%)

0.61

0.72 (0.21-2.5)

0.17

3.9 (0.75-20.0)

0.52

0.67 (0.20-2.3)

6 (32%)
13 (68%)

2 (11%)
17 (49%)
7 (37%)
12 (63%)
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Table 11: Comparison of PSQI Scores between FM and FBS Patients.
PSQI Score
Group
Mean
SD

P+

PSQI Total Score

FM
FBS

12.9
12.0

3.9
4.6

0.45

Subjective Sleep Quality

FM
FBS

1.8
1.7

10
0.7

0.77

Sleep Latency

FM
FBS

1.9
2.1

0.9
10

0.59

Sleep Duration

FM
FBS

1.7
2.1

0.9
0.9

0.21

Sleep Efficiency

FM
FBS

1.3
1.8

1.2
1.3

0.20

Sleep Disturbances

FM
FBS

2.0
1.7

0.7
0.5

0.10

Use of Sleep Medication

FM
FBS

2.4
1.3

1.0
1.3

0.002*

Daytime Sleep
Dysfunction

FM

1.8

1.0

0.06

FBS

1.3

1.0

+

two sample t test
SD=standard deviation
* Statistically significant difference
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Table 12: Comparison of Reported Stressful Life Events between FM and
FBS Patients.
Reported a Stressful Life
FM
FBS
P*
Odds Ratio (95%
Event
(n=30)
(n=18)
C.I.)
Yes
No
* Fisher’s exact test
n=number of patients
%=percentage

26 (87%)
4 (13%)

10 (56%)
8 (44%)
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0.036

5.2 (1.3-21.2)

Table 13: Comparison of PTSD Symptoms between FM and FBS Patients who
Reported Stressors.
PTSD Symptoms FM
FBS
P*
Odds Ratio (95%
(n=26)
(n=10)
C.I.)
Positive
11 (42.3%)
Negative
15 (57.7%)
*Fisher’s exact test
n=number of patients
%=percentage

3 (30%)
7 (70%)
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0.71

1.7 (0.36-8.2)

Table 14: Comparison of Fatigue-related Symptoms (MFSI-SF) between FM and FBS
Patients
Fatigue-related
Group
n
Mean
SD
P+
Symptoms

+

General

FM
FBS

32
19

3.1
1.8

0.8
1.1

<0.0001*

Emotional

FM
FBS

32
19

2.1
1.2

1.0
1.0

0.008*

Physical

FM
FBS

32
19

2.6
1.4

0.8
0.9

<0.0001*

Mental

FM
FBS

32
19

2.4
1.1

1.0
0.8

<0.0001*

Vigor

FM
FBS

32
19

1.3
1.6

0.7
0.8

0.15

two sample t test.
N=number of patients
SD=standard deviation
* Statistically significant difference
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Table 15: Correlations between PSQI Scores and Fatigue-related Symptoms
(MFSI-SF) among FBS Patients.
Emotional Physical
Mental
Vigor
General
(n)
(n)
(n)
(n)
(n)
(correlation+) (correlation+) (correlation+) (correlation+) (correlation+)
(P)
(P)
(P)
(P)
(P)
Variable
19
0.45
0.053

19
0.50
0.03*

19
0.55
0.02*

19
0.50
0.03*

19
-0.44
0.06

Subjective Sleep Quality

19
0.27
0.26

19
0.28
0.25

19
0.32
0.19

19
0.42
0.07

19
-0.07
0.78

Sleep Latency

19
0.08
0.74

19
0.46
0.047*

19
0.40
0.09

19
0.08
0.73

19
-0.22
0.36

Sleep Duration

19
0.34
0.15

19
0.38
0.11

19
0.56
0.01*

19
0.39
0.10

19
-0.28
0.25

Sleep Efficiency

19
0.35
0.14

19
0.32
0.18

19
0.46
0.046*

19
0.46
0.0496*

19
-0.45
0.06

Sleep Disturbances

19
0.33
0.17

19
0.22
0.36

19
0.52
0.02*

19
0.23
0.35

19
-0.54
0.02*

Use of Sleep Medication

19
0.27
0.26

19
0.31
0.19

19
0.05
0.85

19
0.16
0.52

19
-0.24
0.32

19
Daytime Sleep Dysfunction
0.49
0.03*
* Statistically significant difference
+ Pearson’s correlation

19
0.36
0.12

19
0.48
0.04*

19
0.64
0.003*

19
-0.35
0.14

PSQI Total Score
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Table 16: Correlations between PSQI Scores and Fatigue-related Symptoms (MFSI-SF)
among FM patients.
Emotional Physical
Mental
Vigor
General
(n)
(n)
(n)
(n)
(n)
(correlation+) (correlation+) (correlation+) (correlation+) (correlation+)
(P)
(P)
(P)
(P)
(P)
Variable
32
0.50
0.004*

32
0.43
0.01*

32
0.40
0.02*

32
0.45
0.01*

32
-0.28
0.11

32
0.41
0.02*

32
0.15
0.40

32
0.19
0.31

32
0.08
0.65

32
-0.15
0.42

Sleep Latency

32
0.35
0.0499*

32
0.37
0.04*

32
0.25
0.17

32
0.59
0.0004*

32
-0.15
0.41

Sleep Duration

31
0.50
0.004*

31
0.33
0.07

31
0.23
0.22

31
0.19
0.30

31
-0.30
0.10

Sleep Efficiency

31
0.38
0.03*

31
0.17
0.36

31
0.06
0.74

31
0.27
0.14

31
-0.15
0.42

Sleep Disturbances

32
0.18
0.33

32
0.28
0.12

32
0.23
0.21

32
0.22
0.24

32
-0.24
0.18

Use of Sleep Medication

32
0.09
0.63

32
0.24
0.18

32
0.31
0.08

32
0.34
0.06

32
-0.04
0.82

Daytime Sleep Dysfunction

32
0.21
0.25

32
0.21
0.24

32
0.33
0.06

32
0.15
0.41

32
-0.23
0.21

PSQI Total Score

Subjective Sleep Quality

* Statistically significant difference
+ Pearson’s correlation
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Chapter 6. Discussion

This study investigated the prevalence of symptoms and signs of TMD in
FM patients compared to another chronic pain patient sample, namely FBS. Fifty
three percent of the FM patients compared to 11% of the FBS patients reported
face pain. In this study FM patients were 9.6 times more likely to report face pain
than the FBS patients. The greater prevalence of face pain among FM patients
compared to FBS patients seems logical based on the definition of FM as a form
of non-articular rheumatism characterized by widespread muscle pain,
tenderness to palpation and stiffness of the locomotor system

94

. It seems

reasonable that FM may encompass TMD, which is a collective term embracing
a number of clinical problems that involve the masticatory musculature, the TMJ
and associated structures 8. Other studies have reported facial pain prevalence
between 68-97% in FM patients 99 128 138 136.
Of the FM patients who reported face pain, 71% met the clinical RDC
criteria for TMD. The prevalence of TMD among FM patients in the current study
is consistent with a study by Plesh et al. that reported that 75% of FM patients
met the RDC criteria for TMD

129

. Interestingly, 47% of FM patients who did not

report face pain also had the relevant signs meeting the clinical RDC criteria for
TMD. Previous studies have reported incongruence between reported TMD
symptoms and the clinical finding of TMD signs. Patients may not report nontroublesome symptoms, whereas the clinician may find signs that are clinically
significant

9 34

. Therefore, prevalence values of previous TMD studies may
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overstate the clinical significance of the patient complaints and thus mild and/or
transient symptoms and signs may inadvertently be misinterpreted and lead to
over treatment 8. Alternatively, failure to report face pain among FM patients who
had TMD signs may be due to the fact that these patients may have assumed or
had been previously informed that their face pain was an extension of the FM
pain, rather than a separate entity.
FM patients who met the clinical criteria for RDC muscle diagnoses
included 32% who had myofascial pain and 42% who had myofascial pain with
limited opening. Therefore, muscle pain was diagnosable in 74% of the FM
patients. This prevalence of muscle pain among FM patients was lower than had
been previously reported in other studies

99 129 128 138

. This may be due to the

examiner in this study being blinded as to primary diagnosis (FM or FBS) of the
recruited patients, therefore diminishing possible selection bias. In addition, many
of the previous studies did not use the RDC for TMD criteria and rather relied on
patient reported symptoms alone 128 138 or carried out clinical examination without
established diagnostic criteria 99.
Disk displacement with reduction was diagnosed among 21% of FM
patients. It should be noted that this diagnosis included painless clicking of the
TMJ that may be coincidental and not clinically relevant to FM. It has been
reported that disk displacement with reduction, which includes clicking of the
TMJ, may occur in a third of asymptomatic patients and therefore should not be
used as an exclusive sign of the presence of TMDs requiring treatment 153.

56

Arthralgia was diagnosed in 16% of the FM patients and TMJ
osteoarthritis was diagnosed in 26% of FM patients. Therefore, 42% of TMJs of
FM patients were painful on palpation and during function. A previous study,
reported that 80% of FM patients had pain or tenderness upon palpation of the
TMJ. However, this study did not use the RDC criteria for TMD and therefore
comparisons with our results were not possible

136

. Osteoarthrosis of the TMJ

was diagnosed in 37% of FM patients. This may be an underestimation as
radiographic imaging of the TMJs, was not performed. Therefore, TMJs that
”exhibit erosion of normal cortical delineation, sclerosis of parts or all of the
condyle and articular eminence, flattening of joint surfaces and osteophyte
formation that did not exhibit crepitus”

24

may have been missed and this could

potentially lead to an underdiagnosis of TMJ osteoarthrosis in the present
sample.
Previous studies have highlighted significant psychological symptoms
among FM patients 154 118 115. The FM patients had elevated SCL-90-R scores on
somatization, obsessive-compulsive, and depression symptoms subscales as
defined by a subscale score ≥63. Of interest were elevated subscale scores
among FM patients for somatization (P=0.02) and obsessive-compulsive
(P=0.009) compared to the FBS group. Studies comparing psychosocial findings
between patients with FM and patients with rheumatoid arthritis suggested an
association between FM and somatization
119

155 121

and obsessive compulsiveness

. It has been established that FM patients present with multiple symptoms

given the comorbidities associated with the syndrome, i.e. pain, sleep
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disturbances, fatigue, etc.

5 7

. The multiple symptoms of FM may be expressed

as somatization and this in turn results in an internal focus on one’s health. The
reverse is also likely whereby internal focus on one’s health may lead to
somatization. This preoccupation with internal somatic states may manifest itself
as elevations of depression and obsessive-compulsive symptoms in an attempt
to cope with the FM symptoms. It would not be surprising that obsessivecompulsive symptoms may represent cognitive and behavioral adaptation to
pain. Compromised cognitive, affective and behavioral responses could result
from excessive long-term preoccupation with one’s health. This may lead to
dysregulatory psychopathology and maladaptive behavioral responses

156

. In

turn, maladaptive behavioral responses may lead to maladaptive physiological
response which is understood to be a failure in inhibitory control and therefore
perpetuate the symptoms of FM

114 71 157 158

.

The combination of the autonomic, attentional and affective systems into a
dynamic functional and structural network enables the living system to selforganize

71 114

. As described by Thayer and Lane (2000), these systems are

likely modulated by inhibitory processes which in turn enable sustained
functioning of the living system when confronted by stressors. Hence, in a
compromised system such as that of FM patients, dis-inhibition (inhibitory failure)
in the face of changing environmental demands may lead to maladaptive
behavior which in turn, may hinder recuperation and normal functioning

114

. The

lack of significant differences among other SCL-90-R subscales between the two
groups may be due to the fact that both FM
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118 115

and FBS

159 160

are chronic

debilitating conditions that are frequently associated with psychosocial
symptoms.
In the present study, FBS patients exhibited an elevation of the
somatization score on the SCL-90-R. Previous studies have suggested that
abnormal preoperative psychological features including depression, hysteria,
hypochondriasis, conversion and somatization may predispose patients to
greater post-operative pain after lumbar disk surgery

161

. Others have suggested

that FBS patients have “emotional problems” including elevated depression and
somatic pain scores

162 163

. Numerous studies have suggested poor outcomes

involving reoperation of FBS patients with psychological problems

164 165 166 167

.

Therefore, it is not surprising that FBS patients in the present study exhibited
elevation of the somatization subscale score on the SCL-90-R.
Based on the PSQI total score, both the FM and FBS patients were
considered poor sleepers defined by a PSQI total score of >5. Previous studies
have associated poor sleep quality with FBS

168 169

. It has been postulated that

poor sleep may contribute to the pain complaint of FBS

169

. Further studies on

sleep disturbances are needed to understand its role in FBS. On the other hand,
it has been well established that FM patients frequently complain of disturbed,
non-refreshing sleep

96

1

. Likewise, healthy patients may express FM-like

symptoms if their normal sleep architecture is disturbed

127

. It is not understood

whether increased pain in FM patients may contribute to sleep disturbances or
sleep disturbances may result in increased pain among FM patients

79

.

Interestingly, apart from FM patients having a significantly larger score for use of

59

sleep medication, both groups of patients were not different with respect to all
other PSQI scores. Use of sleep medication among FM patients is common and
often prescribed as part of the treatment for poor sleep related to FM. Sedatives,
such as benzodiazepines, zolpidem tartrate, zaleplon, antidepressants, such as
amitriptyline and muscle relaxants, such as cyclobenzaprine, are often used to
improve sleep

170 171 172

Therefore, the implied causative relationship of FM

symptoms with poor sleep (architecture) could explain the higher use of sleep
medications endorsed by FM patients compared to FBS patients.
There is a strong relationship between sleep and chronic pain

79 80 81 82

.A

previous study reported that stage-four deprivation led to muscle tenderness and
stiffness in healthy subjects, but such musculoskeletal symptoms were not
observed following disruption of the rapid eye-movement (REM) sleep. Therefore
poor sleep quality of the deeper sleep stages may be linked to chronic pain
conditions. This may be a consequence of the failure to restore the functions of
the body systems such as metabolic processes that occur in deeper sleep stages
84

. Although speculative, poor deep sleep quality may lead to musculoskeletal

pain, which in turn, may contribute to a fragmented sleep cycle.
Previous literature suggests that PTSD may coexist with FM

173 174

.

Suggestions that the two entities exist because of care seeking selection bias
among FM patients, failure of FM patients to cope with life stress and
confounding arousal symptoms between PTSD and FM has been refuted

175

.

Although exploratory, it is likely that FM and PTSD share psychobiological risk
factors

175

. A significantly higher number of FM patients (87%; P=0.036) than

60

FBS patients (56%) reported a stressful life event. Of those FM patients who
reported a stressful life event, 42.3% were PTSD positive based on a score of
greater than 41 on the PCL-C. Previous studies reported that more than 50% of
FM patients had significant levels of PTSD symptoms

174 173

. Sherman et al.

found in a sample of FM patients that pain level, disability and affective distress
was greater in those patients reporting PTSD symptoms than those who did not
report such symptoms. Sherman and colleagues suggested that PTSD-like
symptoms may influence the adaptative ability of FM patients. Therefore, failure
to assess the presence of these symptoms may impede successful outcomes 173.
Further studies are required to elucidate the relationship between FM and PTSD.
Presence of fatigue-like symptoms among FM patients has been
previously reported

96 1 135 7

. FM patients had significantly higher general,

emotional, physical and mental fatigue scores than FBS patients. FM has been
shown to have comorbidity with chronic fatigue syndrome, and patients often
share common symptoms

176 177 178 135 179 180

. Both conditions are marked by a

heightened sensitivity to physical and psychological stress

96 97 7 98

. Previous

studies have revealed that fatigue in chronic pain was related to symptoms of
somatization and depression and to a far lesser degree sleep disturbances
181

. In fact, it has been reported that somatization

152 181

and depression

181

152

are

major predictors of fatigue. It is likely that the multiple symptoms of FM such as
wide spread pain, fatigue, sleep disturbances etc. may be the result of high
somatization and depression scores in FM. That is, preoccupation with one’s
health may manifest as elevations of depression and somatization symptoms in

61

an attempt to cope with the FM symptoms. The failure to cope may result in
dysregulation of autonomic nervous system and in turn compromised cognitive,
affective and behavioral responses apparent as fatigue-like symptoms

182 156

.

Maladaptive behavioral responses may lead to maladaptive physiological
response and therefore perpetuate the fatigue-like symptoms of FM

157 158

.

Interestingly, sleep disturbances are frequently reported by chronic pain patients
but are not thought to be the cause of fatigue

181

. Both the FM and FBS patients

had sleep disturbances based on the PSQI but there were no significant
differences between the two groups. However, the FM patients were significantly
more fatigued than the FBS patients. Interestingly, both FM and FBS patients
revealed correlations between one or more PSQI scores and fatigue-related
disturbances. This study is not in agreement with previous studies that suggests
that fatigue is unrelated to quantitative measures of sleep 181 183.
The high prevalence of TMDs and psychosocial distress among FM
patients could be manifestations of either a dysfunctional HPA axis, and/or a
dysregulated autonomic nervous system and in turn results in alterations of the
peripheral and central pain facilitation and inhibitory pain mechanisms

97 140

.

Therefore, a facilitation or failure in inhibition of nociception may lead to central
sensitization and increased pain perception. This in turn may affect the dynamic
equilibrium of the system and shift it from an adaptive physiological state to that
of dysfunction and pathology

114 71

. This may further explain the comorbidity of

FM with other conditions such as chronic fatigue syndrome, IBS and interstitial
cystitis, which may be related to a reduction in pain threshold and tolerance

62

mediated by central nervous system mechanisms. In addition, these conditions
are marked by a heightened sensitivity to both physical and psychological stress
96 97 7 98

. Therefore, the multiple symptoms presentation of FM, which may

include

pain,

compulsiveness,

non-restorative
and

sleep,

somatization,

is

fatigue,
likely

depression,

influenced

by

obsessivemaladaptive

physiological states.
The sociodemographic data revealed that all FM patients were females
and this was significantly different when compared to the FBS patients. This is
consistent with other reports that suggest FM is more prevalent among women
94

1

. The mean age of FM patients in this study was 52 years and other studies

have suggested a similar age distribution of FM among women in the general
population 94 2 184.
Sixty-six percent of the FM patients were unemployed and 53% were
receiving disability. Previous studies have reported that 30% of FM patients
worked shorter hours or less physically demanding jobs and 15% received
disability from inability to work
patients were unable to work

129

185 91 92

. Another study reported that 41% of

. The large number of unemployed subjects and

subjects receiving disability in the current study may be a result of the
recruitment protocol. Patients in this study were recruited from a Physical
Medicine and Rehabilitation clinic and a FM workshop possibly targeting subjects
who are actively seeking treatment and who may have greater severity of the
condition.
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A previous study reported that 22% of FM patients smoke tobacco and the
study adjusted for age and education level

186

. Interestingly, in the current study

only one FM patient used tobacco and this was significantly different compared
to FBS patients. Recent data on the prevalence of smoking in the United States
reported that 23.4% of males and 18.5% of females in the total population smoke
187

. Therefore, a rational explanation of the low prevalence of tobacco use among

FM patients in this study is difficult. Further research on the use of tobacco
among FM patients is required to establish its prevalence. Interestingly, 42% of
the FBS patients in this study used tobacco. It has been suggested that heavy
tobacco use is common among FBS patients

142

and is a major risk factor for

developing lower back pain 188 189 as well as failure of bony union associated with
FBS 190.
The present study has limitations in spite of its prospective design. A
major concern of this study was the small sample sizes in each of the groups.
Therefore, detailed statistical analysis of the study variables was not possible.
Another major concern was that the study involved FBS patients as a control
group which many consider a poorly defined clinical condition 141 142 143. Similarly,
much debate persists on whether FM as a clinical condition exists. As a result,
comparisons between two poorly defined conditions may have led to
questionable findings and interpretation. On the other hand this was the first
study that investigated the prevalence of TMDs in FM that employed a chronic
pain population sample for comparisons.
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Because of the recruitment protocol, the participating patients may not
represent a sample of the general population. All patients were actively seeking
treatment for their condition at a tertiary care center and this may have resulted
in an overestimation of the prevalence of TMDs among FM patients. In addition,
the prevalence of psychosocial distress in both FM and FBS patients may not be
a representative of the subjects with these conditions in the general population.
Therefore, the patients in this study could represent a selective pain population
compared to those patients seen at a general practice.
With respect to the prevalence of TMD, the RDC embraces all TMD
diagnoses, including painless clicking and crepitation of the TMJs. As previously
discussed, asymptomatic clicking of the TMJ and TMJ crepitation without
imaging evidence of condylar bone remodeling may be coincidental and not be of
clinical relevance. Therefore, this may have led to an overestimation of the
prevalence of TMDs in FM patients.
Finally, the subjects in this study were required to complete a history form
that was not verified in an interview. Hence, errors in reporting may have
occurred. Additionally, since the examiner was blind to diagnostic category,
further verification of the information supplied by the patient was not accessible
at the time of the clinical examination. Similarly, the blinded examination was
performed by one dentist who was not calibrated in accordance to the RDC for
TMD 191 192 193. Therefore, the reliability of the clinical finding was not determined.
However, the clinical findings were verified by two other dentists trained at the
University of Kentucky, Orofacial Pain Center. If there was a disagreement
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between the two dentists as to the RDC diagnoses for TMDs, a discussion was
held between the two dentists and the dentist that performed the blind
examination and consensus as to the appropriate diagnoses was reached.

Copyright © 2006, Ramesh Balasubramaniam
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Chapter 7. Conclusion
The present study replicates and extends previous investigations
addressing the relationship between TMD and FM. Fifty three percent of FM
patients reported face pain. Of those FM patients who reported face pain, 71%
fulfilled the RDC criteria for TMD. Interestingly, 47% of FM patients who did not
report face pain also fulfilled the RDC criteria for TMDs. Therefore, this study
confirms our hypothesis that the prevalence of TMD is greater among FM
patients than among FBS patients. Both the FM and FBS patients reported high
levels of psychosocial distress, but somatization, obsessive compulsive, fatigue
and medication needed for sleep disturbances were significantly higher for FM
patients than for FBS patients. Eighty seven percent of the FM patients also
reported a stressful event and approximately 42% of these patients were PTSD
positive. These results suggest that a dysfunctional HPA axis and dysregulation
of the autonomic nervous system are linked to the high prevalence of TMD and
significant psychosocial distress among FM patients.

Copyright © 2006, Ramesh Balasubramaniam
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Appendix 1: Orofacial Pain Questionnaire Form

ID __________
Date_____________
Your reason for visiting the clinic today? [ ] Fibromyalgia

[ ] Lower back pain

Age:___________ Date of Birth:__________________ Sex: [ ]Male
Marital Status: [ ] Single

[ ] Married

[ ] Divorced

[ ]Female

[ ] Widowed

Number of Children__________
Are you presently employed?

[ ] Yes

[ ] No

Occupation:______________________________________________________
Education:

[
[
[
[
[
[

] Completed High school
] Completed Associate or Technical Degree
] Completed College Degree (BS/BA)
] Completed Professional Degree (i.e., MD, JD, MBA)
] Completed Graduate Degree (i.e., MS, PhD)
] Did not complete any of the above

******************************************************************************
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OROFACIAL PAIN STUDY QUESTIONNAIRE

In this questionnaire we are interested in your face or jaw pain and headaches. Please do not
answer these questions below with regard to back pain or fibromyalgia.

1.

Do you currently have pain in your face or jaw? [ ] Yes
If no, go to question 10

2.

If yes, when did your face/jaw pain begin? _____________________
(month / date / year)

3.

How did your face/jaw pain begin?
[
[
[
[
[
[

4.

[ ] No

]Jaw Surgery
[ ]Blow to jaw / head / neck
]Motor vehicle accident
[ ]Dental work
]Chewing
[ ]Tooth extraction
]Orthodontics (braces)
[ ]Stressful Situation
]Nothing; pain just came on
]Other____________________________________________________

What is the usual severity of your face/jaw pain? (Circle the appropriate number)
|_____________________________________________________________|
0
No Pain

5.
[
[
[
[
[

1

2

3

4

5

6

7

Describe the way your face/jaw pain typically feels:
] Throbbing
] Shooting
] Stabbing
] Sharp
] Cramping

[
[
[
[
[

] Gnawing
] Hot / Burning
] Aching
] Heavy
] Tender

[
[
[
[
[

] Splitting
] Tiring-exhausting
] Sickening
] Fearful
] Punishing - Cruel
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8

9

10
Extreme Pain

6. Where is your face or jaw pain located? Please check the following areas based on the location
of your pain.
1. Forehead

[ ] Right side [ ] Left side

[ ] Both sides

2. Temples

[ ] Right side [ ] Left side

[ ] Both sides

3. Inside the ear

[ ] Right side [ ] Left side

[ ] Both sides

4. Jaw joint

[ ] Right side [ ] Left side

[ ] Both sides

5. Jaw

[ ] Right side [ ] Left side

[ ] Both sides

7.

How long does your face or jaw pain typically last?
[
[
[
[

8.
[
[
[
[
[
[

]Less than 1 minute
]1-10 minutes
]Less than 1 hour
]1-5 hours

[
[
[
[

]6-12 hours
]13-24 hours
]Several days
]Constant

Which of the following causes or aggravates your jaw or face pain?
]Chewing
[ ]Opening mouth wide
[ ]Hot or cold foods/drinks
]Talking
[ ]Lack of sleep
[ ]Damp or cold weather
]Yawning
[ ]Playing musical instrument
[ ]Stress/emotional upset
]Laughing
[ ]Riding in car for long period
[ ]Sitting for long period
]Singing
[ ]Eating certain foods
[ ]Exercise
]Other_________________________________________________________
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9.
[
[
[
[
[

Which of the following relieves the pain?
]Exercise
[ ]Massage of the area
[ ]Warm soak/compresses
]Heat
[ ]Holding jaw in certain position [ ]Ice/cold compresses
]Sleep
[ ]Moving/manipulating jaw
[ ]Pain medication
]Time
[ ]Relaxation
[ ]Nothing helps
]Other_________________________________________________________

10.

Do you have any painful teeth or other painful areas in your mouth?
[ ]Yes
[ ]No
If Yes, please check the following based on the location of
your pain.
Teeth
Tongue
Gums
Roof of mouth
Cheek

11.

[
[
[
[
[

] Yes
] Yes
] Yes
] Yes
] Yes

[
[
[
[
[

] No
] No
] No
] No
] No

Are you bothered by headaches?
[ ]Yes
[ ]No

If no, skip to question number 12.

1) How painful are your headaches usually?

|____________________________________________________________|
0
No Pain

1

2

3

4

5

6
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7

8

9

10
Extreme Pain

2) Do you have headaches as often as once per week?
[ ]Yes
[ ]No
3) How long do your headaches last?
[ ] less than 1 hour
[ ] greater than 24 hours

[ ] greater than 1 hour but less than 24 hrs
[ ] constant headache

4) Is there any nausea or vomiting associated with your headaches?
[ ]Yes
[ ]No
5) Are there vision changes associated with your headaches?
[ ]Yes
[ ]No
6) Are you disabled (unable to function normally) by your headaches?
[ ]Yes
[ ]No
7) Has a doctor diagnosed you with
[ ] Migraine
[ ] tension type headache
[ ] Other __________________________________

12.

Are you aware of your jaw making sounds?
[ ]Yes [ ]No

If yes, please answer the following questions, if no, go to question #13.
Which side?

[ ]Right

[ ]Left

[ ]Both sides

Describe the nature of the sound:
[ ]Clicking
[ ]Grating
[ ]Popping
[ ]Cracking
[ ]Other___________________________________________________
When do you notice the sounds?
[ ]Early opening
[ ]Moving jaw to the side
[ ]Middle opening
[ ]Chewing
[ ]Wide opening
[ ]While closing
Is the sound always present?
[ ]Yes

[ ]No

Do you feel that the sounds are related to your jaw or face pain or headaches:
[ ]Yes
[ ]No
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13

Has your jaw ever locked open?
[ ]Yes
[ ]No

[ ]Right side
[ ]Left side

Date of first occurrence________________________
14

[ ]Both sides

(month / date/ year)

Has your jaw ever locked closed or partially closed?
[ ]Yes
[ ]No

[ ]Right side
[ ]Left side

[ ]Both sides

Date of first occurrence__________________________(month / date/ year)
15

How many times has your jaw locked open or closed during the past year?
[ ] none # of times___________

16

Do you have pain when your jaw locks open or closed?
[ ]Yes

[ ]No

17
Have you noticed any other oral habits or practices that aggravate or cause your face /jaw
pain or headaches?
[
[
[
[
[

]Clenching the teeth
[ ]Grinding the teeth
]Chewing ice
[ ]Chewing finger nails
]Chewing pencil/paper clips
[ ]Chewing cheek/lips
]Chewing gum
[ ]Playing wind instruments/violin
]Holding phone between ear and shoulders [ ]Other_________________________

18.
For each of the beverages listed below, write in the average number that you will drink
each day:
Caffeinated coffee
_____cups/day
Caffeinated soft drink
_____cans/bottles/day
Caffeinated Tea
_____cups/day
Decaffeinated beverages including juices and milk _____cups/day
Alcoholic beverages ____ drinks/cans/day
Water ________ cups/day

19.

Do you use tobacco?

[ ] no [ ] yes
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20.

21.

Are you receiving or applying for disability? [ ] no [ ] yes
For :
[ ] Face or jaw pain
[ ] Fibromyalgia
[ ] Chronic lower back pain
[ ] Depression / Anxiety
[ ] Other, please specify _________________
Are you taking or supposed to be taking and medicine, drugs or pills of any kind?
Taking
Supposed to be taking
_______________________
____________________
_______________________
____________________
_______________________
____________________
_______________________
____________________
_______________________
____________________
_______________________
____________________
_______________________
____________________
_______________________
____________________
_______________________
____________________
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University of Kentucky Orofacial Pain Questionnaire
General Medical History

Please check the box for any condition which you have had in the past or have now.
(1) Cardiovascular

(4) Gastrointestinal

(7) Endocrine

Congestive Heart Failure

Stomach/Intestinal Ulcers

Diabetes

Heart Attack

Colitis

Thyroid Disease

Angina Pectoris or Chest Pain

Irritable Bowel Syndrome

High Blood Pressure

Persistent Diarrhea

Taking Cortisone or Other
Steroids

Heart Murmur

Hepatitis

Mitral Valve Prolapse

Liver Disease

Rheumatic Fever

Yellow Jaundice

Congenital Heart Defect

Cirrhosis

Artificial (Prosthetic) Heart
Valve

Eating Disorder

Hormone Replacement Therapy

(8) Genitourinary
Urinate Frequently
Kidney, Bladder Problem

Gastric Acid Reflux

Arrhythmias

Dialysis
Kidney Transplant

Coronary By-Pass

Hay Fever

Sexually Transmitted Disease
(Syphilis, Gonorrhea, Chlamydia
or Genital Herpes)

Coronary Angioplasty

Sinus Trouble

HIV Positive

Heart Transplant

Allergies or Hives

Multiple Sexual Partners

Aneurysm

Asthma

Interstitial Cystitis

Other Heart Problems

Chronic Cough

Endometriosis

Heart Pacemaker or Defibrillator

(5) Pulmonary

Emphysema

(2) Hematologic

Chronic Bronchitis

(9) Other Conditions

Blood Transfusion

Tuberculosis (TB)

Anxiety Disorder

Anemia

Breathing Difficulties

Depression

Hemophilia

Sarcoidosis

Frequent Sore Throats

Leukemia
Sickle Cell Anemia
Tendency to Bleed Longer Than
Normal

(6) Dermal /
Musculoskeletal

Enlarged Lymph Node or
“Gland”
Use Tobacco

Allergy to Latex (Rubber)

Use Alcohol

Skin Rash

Use Injectable Drugs

Vision Problems

Dark Mole(s) (Recent changes in
appearance)

Drug or Alcohol Addiction
(Recovery or Current)

Glaucoma

Osteoarthritis

Tumor or Cancer

Earache, Ringing in Ears

Rheumatoid Arthritis

Radiation Therapy

Hearing Loss

Systemic Lupus

Chemotherapy

Severe Headaches

Artificial (Prosthetic ) Joint

Sleep Apnea

Fainting or Dizzy Spells

Fibromyalgia

Snoring

Stroke

Chronic Fatigue Syndrome

Epilepsy, Seizures or
Convulsions

Scleroderma

(3) Neurologic

Psychiatric Treatment
Panic Attacks

Sjogren’s Syndrome
CRPS I (RSD)
CRPS II (Causalgia)

Phobias
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Disease, Problem or Condition
not listed
If yes, list
_____________________________
_____________________________
_____________________________
_____________________________
_____________________________

Appendix 2: Orofacial Pain Examination Form

ID: ___________________

Date:___________
Orofacial Pain Examination

Cranial Nerve Examination:
(II)

Gross Vision,

WNL:_________________________________________

(III)

(III, IV, VI) Extraocular Muscles

WNL:_________________________________________

Pupils (Equality, Reaction, Accommodation) WNL:____________________________________
(V)

Sensory (V1, V2, V3)

(V)

Motor (Function, Symmetry)

(VII)

Motor (Facial Muscles)

WNL________________________________________________

(VIII) Gross Hearing

WNL:__________________________________________
WNL:______________________________________________________

EAC and TM
(IX, X) Gag Reflex

WNL:__________________________________________

WNL:_____________________________________________________
WNL:______________________________________________________

(XI)

Shoulder Shrug/Lateral Head Movement WNL:____________________________________

(XII)

Tongue Protrusion

WNL:______________________________________________________

Balance/Coordination:
WNL :_________________________________________________________________________
(Tests: finger to nose; alternate hands; toe to heel walking)

Cervical Range of Movement:
Restriction

Pain
Flexion / Extension

None

Ex

Flex

None

Ex

Flex

Rotation (70 degrees)

None

Right

Left

None

Right

Left

Lateral Tilt (60 degrees) None

Right

Left

None

Right

Left

General Comments:________________________________________________________________
________________________________________________________________________________
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Muscle and Joint Palpation Examination:
Codes: 0= no pain, 1= tenderness, 2= pain, 3= pain with withdrawal, T= trigger point,
(if there is pain referral, draw an arrow to depict direction and location)
Right
Left
Temporalis
Anterior
_____
_____
Middle
_____
_____
Posterior
_____
_____
Masseter
Superior
_____
_____
Inferior
_____
_____
SCM
_____
_____
Occipital
_____
_____
Trapezius
_____
_____
Paracervical
_____
_____
Cervical Spine
_____
TMJ
Lateral Capsule
_____
_____
EAC
_____
_____
Splenius Capitis
_____
_____
Provocation Tests:

Pain on Mandibular Function:
pain with opening: [ ] No [ ] Right [ ] Left
pain with clenching: [ ] No [ ] Right [ ] Left
with right lat movement: [ ] No [ ] Right [ ] Left
with left lat movement:
[ ] No [ ] Right [ ] Left

Clenching on separator:
bilaterally: [ ] No [ ] Right [ ] Left
right: [ ] No [ ] Right [ ] Left
left: [ ] No [ ] Right [ ] Left
Resisted Movements:
resisted protrusion: [ ] No [ ] Right [ ] Left
resisted right lateral: [ ] No [ ] Right [ ] Left
resisted left lateral: [ ] No [ ] Right [ ] Left

Range of Mandibular Movement:
Manual loading of TMJs
[ ] no pain [ ] Right [ ] Left

Closed
10mm

10mm

R ___mm

L ___mm
Max protrusive movement ___mm

Draw
deflection
or
deviations

Max comfortable opening ____mm
Max opening by patient ____mm
Max assisted opening ____mm

or
straight

Opened

End Feel: [ ] Soft [ ] Hard [ ] Not Indicated
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Intracapsular Interferences:
opening click

closing click

Right TMJ [ ] No [ ] Yes at ____mm
Left TMJ
[ ] No [ ] Yes at ____mm

[ ] No [ ] Yes at ____mm
[ ] No [ ] Yes at ____mm

Clicking during:
Right lateral movements: [ ] No [ ] Right [ ] Left
Left lateral movements [ ] No [ ] Right [ ] Left
The click is:
[ ] very repeatable
[ ] not very repeatable
[ ] there is no click

The click is eliminated by protrusion
[ ] No [ ] Yes at ____mm of protrusion
Crepitus: [ ] No [ ] Right [ ] Left

Intraoral Examination:
Intraoral Muscle Palpation:
Temporal Tendon
Medial Pterygoid
Anterior Digastric

Right
_____
_____
_____

Left
_____
_____
_____

Soft Tissue: [ ] WNL _______________________________________________________________
______________________________________________________________________
Periodontal Health [ ] WNL, _________________________________________________________
______________________________________________________________________
General Description of Dentition:_____________________________________________________
______________________________________________________________________
______________________________________________________________________
Tooth Wear: Anterior teeth [ ] none [ ] enamel only [ ] enamel and dentin
Posterior teeth [ ] none [ ] enamel only [ ] enamel and dentin
Occlusal Examination:
Profile: [ ] Orthognathic [ ] Retrognathic

[ ] Prognathic

Anterior tooth relationship: [ ] Class I [ ] Class II, Div 1 [ ] Class II, Div 2

[ ] Class III [ ] Open bite

Posterior tooth relationship: [ ] Class I [ ] Class II [ ] Class III [ ] Open bite (right, left or both)
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Circle the areas of occlusal contacts; cross missing teeth
Non-Working

Intercuspal Position
M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3

R

none

M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3

L

M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3

R

L

M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3

Protrusive

Working Contacts

M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3

R

none

none

M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3

M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3

L

R

none

L

M3 M2 M1 P2 P1 C I2 I1 I1 I2 C P1 P2 M1 M2 M3
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